1. Home
  2. PCRX vs IMXI Comparison

PCRX vs IMXI Comparison

Compare PCRX & IMXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCRX
  • IMXI
  • Stock Information
  • Founded
  • PCRX 2006
  • IMXI 1994
  • Country
  • PCRX United States
  • IMXI United States
  • Employees
  • PCRX N/A
  • IMXI N/A
  • Industry
  • PCRX Biotechnology: Pharmaceutical Preparations
  • IMXI Retail: Computer Software & Peripheral Equipment
  • Sector
  • PCRX Health Care
  • IMXI Technology
  • Exchange
  • PCRX Nasdaq
  • IMXI Nasdaq
  • Market Cap
  • PCRX 604.7M
  • IMXI 619.2M
  • IPO Year
  • PCRX 2011
  • IMXI N/A
  • Fundamental
  • Price
  • PCRX $24.67
  • IMXI $19.70
  • Analyst Decision
  • PCRX Buy
  • IMXI Buy
  • Analyst Count
  • PCRX 10
  • IMXI 6
  • Target Price
  • PCRX $27.60
  • IMXI $27.50
  • AVG Volume (30 Days)
  • PCRX 644.2K
  • IMXI 122.7K
  • Earning Date
  • PCRX 02-27-2025
  • IMXI 02-25-2025
  • Dividend Yield
  • PCRX N/A
  • IMXI N/A
  • EPS Growth
  • PCRX N/A
  • IMXI 21.49
  • EPS
  • PCRX N/A
  • IMXI 1.80
  • Revenue
  • PCRX $694,957,000.00
  • IMXI $665,673,000.00
  • Revenue This Year
  • PCRX $4.83
  • IMXI $2.65
  • Revenue Next Year
  • PCRX $2.16
  • IMXI $2.82
  • P/E Ratio
  • PCRX N/A
  • IMXI $10.92
  • Revenue Growth
  • PCRX 4.40
  • IMXI 3.79
  • 52 Week Low
  • PCRX $11.16
  • IMXI $16.17
  • 52 Week High
  • PCRX $34.01
  • IMXI $23.28
  • Technical
  • Relative Strength Index (RSI)
  • PCRX 75.74
  • IMXI 34.79
  • Support Level
  • PCRX $18.18
  • IMXI $19.73
  • Resistance Level
  • PCRX $22.36
  • IMXI $21.41
  • Average True Range (ATR)
  • PCRX 1.21
  • IMXI 0.45
  • MACD
  • PCRX 0.36
  • IMXI -0.13
  • Stochastic Oscillator
  • PCRX 98.85
  • IMXI 0.00

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.

About IMXI International Money Express Inc.

International Money Express Inc is a processor of money transfer services in the USA to the Latin America and the Caribbean (LAC) corridor. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.

Share on Social Networks: